Introduction
Materials and methods
Patient | Control | |||
---|---|---|---|---|
Osteosarcoma | Ewing-Sarcoma | |||
N | 56 | 58 | ||
34 (60.7%) | 22 (39.3%) | |||
Age (in years) | MV (STD) | 33.9 (± 14.3) | 24.4 (± 3.1) | |
35.5 (± 16.5) | 31.1 (± 9.6) | |||
Male (%) | 39 (69.6%) | 31 (53.5%) | ||
22 (64.7%) | 17 (77.3%) | |||
Female (%) | 17 (30.4%) | 27 (46.5%) | ||
12 (35.3%) | 5 (22.7%) | |||
Years since diagnose | MV (SDT) | 9.1 (± 6.6) | ||
8.2 (± 6.0) | 10.3 (± 7.4) |
Lower limb | Upper limb | Trunk | Chemotherapy | Radiotherapy | |||||
---|---|---|---|---|---|---|---|---|---|
Salivation | Amputation | Yes | No | Yes | No | ||||
N (%) | 42 (75.0%) | 7 (12.5%) | 7 (12.5%) | 48 (85.7%) | 8 (14.3%) | 14 (25.0%) | 42 (75.0%) | ||
37 (66.1%) | 5 (8.9%) | ||||||||
OS (%) | 30 (71.4%) | 3 (42.9%) | 1 (14.3%) | 27 (56.2%) | 7 (87.5%) | 3 (21.4%) | 36 (85.7%) | ||
27 (73.0%) | 3 (60.0%) | ||||||||
ES (%) | 12 (28.6%) | 4 (57.1%) | 6 (85.7%) | 21 (43.8%) | 1 (12.5%) | 11 (78.6%) | 6 (14.3%) | ||
10 (27.0%) | 2 (40.0%) | ||||||||
Age (in years) | MV (SD) | 33.1 (± 6.8) | 33.0 (± 18.5) | 39.0 (± 10.4) | 31.6 (± 11.5) | 47.5 (± 21.7) | 32.6 (± 9.9) | 34.1 (± 15.7) | |
32.7 (± 13.5) | 35.6 (± 20.2) | ||||||||
Male (%) | 27 (64.3%) | 6 (85.7%) | 6 (85.7%) | 36 (75.0%) | 3 (37.5%) | 11 (78.6%) | 28 (66.7%) | ||
24 (64.9) | 3 (60.0%) | ||||||||
Female (%) | 15 (35.7%) | 1 (14.3%) | 1 (14.3%) | 12 (25.0%) | 5 (62.5%) | 3 (21.4%) | 14 (33.3%) | ||
13 (35.1%) | 2 (40.0%) | ||||||||
Since diag (in years) | MV (SD) | 9.75 (± 6.8) | 5.3 (± 4.8) | 8.5 ( ± 6.1) | 9.8 (± 9.6) | 4.9 (± 5.2) | 11.0 (± 6.8) | 8.4 (± 6.5) | |
9.9 (± 6.9) | 8.7 ( ± 7.3) |
Questionnaires
Short-Form (36) Heath Survey (SF-36)
Rosenberg Self-Esteem Scale (RSE)
Multidimensional Body-Self Relations Questionnaire (MBSRQ)
Musculoskeletal Tumor Society Score (MSTS)
Statistics
Conflict of interests
Ethical review committee statement
Results
Patients | Control | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
All | Male | Female | Lower extremity | Upper extremity | Trunk | All | Male | Female | ||
SF36 | PF | 66.79 (± 28.16) | 67.95 (± 28.04) | 64.12 (± 29.11) | 63.45 (± 29.16) | 65.71 (± 27.6) | 87.86 (± 9.94) | 98.02 (± 8.68) | 99.44 (± 1.6) | 98.75 (± 2.24) |
RF | 62.05 (± 42.64) | 66.67 (± 41.49) | 51.47 (± 44.61) | 58.93 (± 43.06) | 57.14 (± 53.45) | 85.71 (± 19.67) | 97.84 ( ± 10.77) | 100 (± 0) | 93.75 (± 19.36) | |
BP | 69.91 (± 28.05) | 71.97 (± 27.53) | 65.18 (± 29.5) | 69.21 (± 27.63) | 70.86 (± 36.64) | 73.14 (± 25.26) | 91.52 (± 13.87) | 91.74 (± 14.82) | 88.56 (± 14.81) | |
GH | 68.20 (± 20.89) | 70.64 (± 19.32) | 62.59 (± 23.79) | 66.14 (± 20.94) | 75.14 (± 22.2) | 73.57 (± 19.81) | 78.59 (± 16.75) | 77.07 (± 18.33) | 76.75 (± 18.42) | |
V | 59.29 (± 19.13) | 61.67 (± 18.26) | 53.82 (± 20.5) | 57.38 (± 17.61) | 60 (± 29.72) | 70 (± 13.84) | 64.66 (± 13.6) | 63.33 (± 14.21) | 65.63 (± 13.89) | |
SF | 81.92 (± 26.75) | 84.29 (± 24.12) | 76.47 (± 32.14) | 82.14 (± 27.49) | 73.21 (± 29.25) | 89.29 (± 19.67) | 89.87 (± 15.08) | 90.28 (± 14.84) | 86.72 (± 17.95) | |
ER | 79.76 (± 35.78) | 85.47 (± 32.26) | 66.67 (± 40.82) | 81.75 (± 34.69) | 71.43 (± 40.5) | 76.19 (± 41.79) | 90.8 (± 24.82) | 96.3 (± 19.25) | 79.16 (± 34.16) | |
MH | 76.57 (± 17.11) | 77.74 (± 15.35) | 73.88 (± 20.89) | 75.62 (± 17.4) | 69.14 (± 17.24) | 89.71 (± 6.87) | 80.55 (± 12.64) | 79.41 (± 13.48) | 77.5 (± 13.14) | |
MBSRQ | AE | 3.58 (± 0.77) | 3.67 (± 0.75) | 3.38 (± 0.82) | 3.56 (± 0.84) | 3.41 (± 0.54) | 3.86 (± 0.52) | 3.99 (± 0.48) | 4.02 (± 0.46) | 3.91 (± 0.51) |
AO | 3.19 (± 0.65) | 3.04 (± 0.53) | 3.55 (± 0.77) | 3.26 (± 0.65) | 3.36 (± 0.4) | 2.67 (± 0.65) | 3.32 (± 0.62) | 3.23 (± 0.6) | 3.42 (± 0.62) | |
FE | 3.64 (± 0.76) | 3.78 (± 0.78) | 3.29 (± 0.6) | 3.6 (± 0.74) | 3.54 (± 0.85) | 3.97 (± 0.78) | 4.05 (± 0.47) | 4.1 (± 0.4) | 3.9 (± 0.58) | |
FO | 3.33 (± 0.88) | 3.5 (± 0.89) | 2.94 (± 0.75) | 3.3 (± 0.86) | 3.49 (± 1.09) | 3.34 (± 0.94) | 4.1 (± 0.65) | 4.03 (± 0.67) | 4.22 (± 0.46) | |
HE | 3.63 (± 0.77) | 3.71 (± 0.77) | 3.43 (± 0.76) | 3.55 (± 0.71) | 3.6 (± 0.99) | 4.14 (± 0.76) | 4.07 (± 0.62) | 4.08 (± 0.65) | 3.93 (± 0.67) | |
HO | 3.56 (± 0.59) | 3.39 (± 0.58) | 3.93 (± 0.42) | 3.5 (± 0.54) | 3.54 (± 0.83) | 3.93 (± 0.57) | 3.77 (± 0.52) | 3.66 (± 0.55) | 3.95 (± 0.35) | |
IO | 3.18 (± 0.77) | 3.17 (± 0.69) | 3.2 (± 0.94) | 3.08 (± 0.8) | 3.71 (± 0.49) | 3.26 (± 0.64) | 3.08 (± 0.74) | 3.14 (± 0.79) | 3.18 (± 0.64) | |
SB | 3.59 (± 0.74) | 3.65 (± 0.77) | 3.43 (± 0.66) | 3.62 (± 0.78) | 3.41 (± 0.55) | 3.56 (± 0.73) | 3.85 (± 0.58) | 3.84 (± 0.6) | 3.87 (± 0.34) | |
∑ | 3.41 (± 0.44) | 3.43 (± 0.48) | 3.38 (± 0.34) | 3.39 (± 0.43) | 3.49 (± 0.53) | 3.48 (± 0.45) | 3.78 (± 0.28) | 3.75 (± 0.3) | 3.81 (± 0.26) | |
Rosenberg | 23.96 (± 5.60) | 23.97 (± 5.35) | 23.94 (± 6.3) | 23.45 (± 6.15) | 23.43 (± 1.9) | 27.57 (± 2.76) | 24.00 (± 5.32) | 24.63 (± 4.29) | 22.81 (± 7.12) | |
MSTS | 17.60 (± 7.39) | 18.66 (± 6.66) | 15.5 (± 8.5) | 17.32 (± 7.62) | 19.29 (± 6.05) |
QoL
Patients vs. control | Male vs. male | Female vs. female | Male patients vs. female patients | Lower extremity vs. control | Upper extremity vs. control | Trunk vs. control | Lower extremity vs. upper extremity | Upper extremity vs. trunk | Lower extremity vs. trunk | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SF36 | PF | */< 0.001 | */< 0.001 | */< 0.001 | ns/0.650 | */< 0.001 | */0.022 | */0.035 | ns/0.847 | ns/0.083 | */< 0.001 |
RF | */< 0.001 | */< 0.001 | */0.001 | ns/0.359 | */< 0.001 | ns/0.092 | ns/0.157 | ns/0.935 | ns/0.223 | */0.015 | |
BP | */< 0.001 | */0.001 | */0.003 | ns/0.425 | */< 0.001 | ns/0.207 | ns/0.104 | ns/0.913 | ns/0.894 | ns/0.716 | |
GH | */0.004 | ns/0.072 | */0.023 | ns/0.229 | */0.013 | ns/0.843 | ns/0.541 | ns/0.347 | ns/0.891 | ns/0.632 | |
V | ns/0.088 | ns/0.634 | */0.039 | ns/0.185 | ns/0.052 | ns/0.726 | ns/0.364 | ns/0.828 | ns/0.442 | ns/0.059 | |
SF | ns/0.055 | ns/0.172 | ns/0.153 | ns/0.377 | ns/0.168 | ns/0.209 | ns/0.942 | ns/0.495 | ns/0.254 | ns/0.423 | |
ER | ns/0.059 | ns/0.159 | ns/0.092 | ns/0.105 | ns/0.228 | ns/0.282 | ns/0.397 | ns/0.543 | ns/0.832 | ns/0.748 | |
MH | ns/0.162 | ns/0.605 | ns/0.174 | ns/0.499 | ns/0.362 | ns/0.203 | */0.012 | ns/0.384 | */0.019 | */0.001 | |
MBSRQ | AE | */0.001 | */0.015 | */0.019 | ns/0.217 | */0.007 | */0.032 | ns/0.555 | ns/0.532 | ns/0.141 | ns/0.238 |
AO | ns/0.302 | ns/0.117 | ns/0.448 | */0.019 | ns/0.757 | ns/0.748 | */0.039 | ns/0.589 | */0.038 | */0.009 | |
FE | */< 0.001 | */0.039 | */< 0.001 | */0.014 | */0.002 | ns/0.189 | ns/0.806 | ns/0.882 | ns/0.344 | ns/0.268 | |
FO | */< 0.001 | */0.017 | */< 0.001 | */0.019 | */< 0.001 | ns/0.193 | ns/0.076 | ns/0.672 | ns/0.782 | ns/0.925 | |
HE | */< 0.001 | */0.010 | */0.017 | ns/0.211 | */0.002 | ns/0.306 | ns/0.826 | ns/0.906 | ns/0.269 | ns/0.089 | |
HO | */0.046 | ns/0.076 | ns/0.806 | */< 0,001 | */0.020 | ns/0.504 | ns/0.496 | ns/0.909 | ns/0.326 | ns/0.098 | |
IO | ns/0.498 | ns/0.848 | ns/0.512 | ns/0.905 | ns/0.642 | */0.025 | ns/0.522 | */0.014 | ns/0.161 | ns/0.521 | |
SB | */0.039 | ns/0.292 | */0.032 | ns/0.284 | ns/0.112 | ns/0.084 | ns/0.345 | ns/0.408 | ns/0.688 | ns/0.839 | |
∑ | */< 0.001 | */0.001 | */< 0.001 | ns/0.839 | */< 0.001 | ns/0.223 | ns/0.138 | ns/0.619 | ns/0.955 | ns/0.624 | |
Rosenberg | ns/0.99 | ns/0.7689 | ns/0.873 | ns/0.974 | ns/0.694 | ns/0.639 | */0.014 | ns/0.984 | */0.008 | */0.009 | |
MSTS | ns/0.255 | ns/0.828 |
Body image
Self-esteem
Gender-specific QoL
Gender-specific body image
Gender-specific self-esteem
Tumor location-related QoL
Tumor location-related body image
Tumor location-related self-esteem
Treatment related QoL, self-esteem and body image
Radiotherapy | No radiotherapy | Radiotherapy vs. no radiotherapy | Chemotherapy | No chemotherapy | Chemotherapy vs. no chemotherapy | Limb salvage | Amputation | Limb salvage vs. amputation | ||
---|---|---|---|---|---|---|---|---|---|---|
SF36 | PF | 78.57 (± 26.05) | 63.41 (± 28.14) | ns/0.067 | 67.35 (± 27.45) | 62.86 (± 34.98) | ns/0.754 | 66.48 (± 28.38) | 40 (± 20.62) | */0.041 |
RF | 67.86 (± 40.94) | 59.15 (± 43.57) | ns/0.552 | 63.78 (± 42.71) | 50 (± 43.3) | ns/0.454 | 60.8 (± 44.59) | 40 (± 37.91) | ns/0.303 | |
BP | 79 (± 27.71) | 67.24 (± 28.08) | ns/0.171 | 70.84 (± 26.57) | 63.43 (± 38.82) | ns/0.640 | 69.73 (± 29.91) | 67 (± 14.73) | ns/0.741 | |
GH | 71 (± 21.54) | 67.15 (± 21.1) | ns/0.577 | 68.43 (± 20.07) | 66.57 (± 27.84) | ns/0.869 | 67.86 (± 21.3) | 63.6 (± 21.45) | ns/0.691 | |
V | 66.79 (± 15.89) | 56.71 (± 19.86) | ns/0.066 | 59.59 (± 17.04) | 57.14 (± 32) | ns/0.849 | 58.07 (± 19.68) | 55 (± 18.37) | ns/0.739 | |
SF | 83.93 (± 29.18) | 80.79 (± 26.38) | ns/0.764 | 83.42 (± 24.12) | 71.43 (± 41.9) | ns/0.485 | 83.52 (± 24.67) | 57.5 (± 42.94) | ns/0.482 | |
ER | 80.95 (± 36.31) | 78.86 (± 36.33) | ns/0.888 | 82.99 (± 33.42) | 57.14 (± 46) | ns/0.195 | 81.06 (± 36.23) | 73.33 (± 27.89) | ns/0.592 | |
MH | 79.43 (± 11.73) | 75.32 (± 18.72) | ns/0.376 | 76.9 (± 15.84) | 74.29 (± 25.91) | ns/0.803 | 75.73 (± 16.87) | 65.6 (± 20.9) | ns/0.348 | |
MBSRQ | AE | 3.45 (± 0.73) | 3.61 (± 0.79) | ns/0.449 | 3.51 (± 0.76) | 4.08 (± 0.75) | ns/0.097 | 3.52 (± 0.8) | 3.71 (± 0.83) | ns/0.644 |
AO | 3.02 (± 0.71) | 3.25 (± 0.64) | ns/0.296 | 3.17 (± 0.62) | 3.36 (± 0.87) | ns/0.603 | 3.27 (± 0.62) | 3.23 (± 0.71) | ns/0.906 | |
FE | 3.83 (± 0.85) | 3.56 (± 0.72) | ns/0.323 | 3.63 (± 0.77) | 3.69 (± 0.71) | ns/0.297 | 3.55 (± 0.77) | 3.88 (± 0.52) | ns/0.257 | |
FO | 3.59 (± 0.65) | 3.23 (± 0.94) | ns/0.134 | 3.36 (± 0.89) | 3.16 (± 0.88) | ns/0.605 | 3.31 (± 0.91) | 3.51 (± 0.68) | ns/0.579 | |
HE | 3.8 (± 0.64) | 3.56 (± 0.81) | ns/0.296 | 3.61 (± 0.74) | 3.76 (± 0.99) | ns/0.704 | 3.55 (± 0.78) | 3.63 (± 0.3) | ns/0.631 | |
HO | 3.63 (± 0.67) | 3.53 (± 0.58) | ns/0.648 | 3.54 (± 0.59) | 3.68 (± 0.59) | ns/0.576 | 3.48 (± 0.6) | 3.73 (± 0.37) | ns/0.231 | |
IO | 3.37 ( ± 0.74) | 3.09 (± 0.77) | ns/0.279 | 3.19 (± 0.76) | 3.11 (± 0.89) | ns/0.840 | 3.19 (± 0.78) | 2.96 (± 0.93) | ns/0.618 | |
SB | 3.52 (± 0.56) | 3.6 (± 0.81) | ns/0.675 | 3.49 (± 0.72) | 4.22 (± 0.58) | */0.019 | 3.55 (± 0.76) | 3.91 (± 0.63) | ns/0.286 | |
∑ | 3.48 (± 0.4) | 3.38 (± 0.45) | ns/0.473 | 3.4 (± 0.46) | 3.5 (± 0.29) | ns/0.443 | 3.39 (± 0.46) | 3.5 (± 0.25) | ns/0.408 | |
RSE | 24.71 (± 3.79) | 23.63 (± 6.16) | ns/0.474 | 23.51 (± 5.73) | 27.14 (± 3.39) | */ 0.035 | 23.61 (± 5.62) | 22 (± 7.11) | ns/0.646 | |
MSTS | 19 (± 7.96) | 17.24 (± 7.4) | ns/0.537 | 17.59 (± 7.37) | 17.71 (± 8.1) | ns/0.969 | 18.6 (± 6.95) | 9 (± 5.57) | */0.014 |